Vesselon Issued Patent and New Data Changes the Therapeutic Index of Antibody-Based Drugs

Drug maker delivers 6X more drug to tumor and less to off-target tissues without altering antibody drugs GREENWICH, Conn., Aug. 26, 2026 /PRNewswire/ -- The U.S. Patent and Trademark Office has issued U.S. Patent Number 12,714,676 to Vesselon titled COMPOSITIONS AND METHODS FOR TARGETED...